Form 4: ADPT Director Sells Shares

Adaptive Biotechnologies Director Robert Hershberg sold 22,968 shares of common stock at $16 per share.

Summary

• Robert Hershberg, a Director at Adaptive Biotechnologies Corp (ADPT), reported the sale of 22,968 shares of common stock.
• The transaction occurred on December 10, 2025, at a price of $16 per share.
• Following this sale, Hershberg beneficially owns 46,722 shares of ADPT common stock directly.

Sentiment

Score: 3

Explanation: The sale of a significant number of shares by a director typically indicates a negative sentiment or at least a lack of strong positive conviction, although it could be for personal financial planning.

Negatives

• A director, Robert Hershberg, sold 22,968 shares of common stock.
• The sale price was $16 per share, totaling $367,488.
• Insider selling can sometimes be interpreted by the market as a lack of confidence in the company's near-term prospects, although it can also be for personal financial planning.

Risks

• Potential negative investor sentiment due to insider selling, which could impact the company's stock price.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Director Robert Hershberg sold 22,968 shares of Adaptive Biotechnologies common stock.

Stakeholder Impact

• Shareholders may interpret the insider sale as a signal of reduced confidence in the company's future prospects, potentially leading to negative stock price movement.

Key Dates

Recommendation

The sale of shares by a director, while potentially for personal reasons, can signal a lack of strong conviction in the company's immediate future. Investors should monitor further insider activity and company performance before making significant investment decisions.

Keywords

Adaptive Biotechnologies, ADPT, Insider Trading, Form 4, Stock Sale, Director Transaction, Robert Hershberg